Core Viewpoint - The company, Gu Han Pharmaceutical (000590.SZ), has stated that its current products and services do not involve AI medical applications. The company is focused on creating a "post-factory" model in the pharmaceutical industry, providing comprehensive lifecycle pharmaceutical services such as R&D, process optimization, and customized production for pharmacies and the pharmaceutical sector [1]. Group 1 - The company is committed to exploring the integration of new technologies with its existing business in response to market developments [1]. - The company aims to provide full lifecycle pharmaceutical services, which include R&D, process optimization, and customized production [1]. - The company emphasizes its dedication to the pharmaceutical industry's "post-factory" model, indicating a strategic focus on enhancing service offerings [1].

Core Viewpoint - The company, Guohan Pharmaceutical, currently does not have any involvement in the AI medical field and is focused on providing comprehensive pharmaceutical services through its "back factory" model [1] Group 1: Company Strategy - Guohan Pharmaceutical is dedicated to creating a "back factory" model in the pharmaceutical industry, offering services such as research and development, process optimization, and customized production for pharmacies and the pharmaceutical sector [1] - The company plans to explore the integration of new technologies with its existing business in response to market developments, although it has not yet ventured into AI medical applications [1]